<div dir="ltr">Hello, everyone. <div><br></div><div>Edits attached. Due to time, forgive my not including them in this email itself. <div><br></div><div>Look forward to the call. <br><div><div><br clear="all"><div><div dir="ltr" class="gmail_signature" data-smartmail="gmail_signature"><div dir="ltr"><div><div dir="ltr"><div><div dir="ltr"><div><font color="#000000" face="Arial"><span style="font-size:13.63636302948px">Sincerely,</span></font></div><div dir="ltr"><span style="border-collapse:separate;font-family:Helvetica;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;font-family:Helvetica;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;font-family:Helvetica;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;font-family:Helvetica;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;font-family:Helvetica;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><font><font face="Arial"><font color="#0000F8" style="font-size:10pt;color:rgb(0,0,0)"><span style="color:rgb(0,0,0)">Jay Chapman</span><b><br></b></font></font></font></span></span></span></span></span></div><div dir="ltr"><span style="border-collapse:separate;color:rgb(0,0,0);font-family:Helvetica;font-size:medium;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;color:rgb(0,0,0);font-family:Helvetica;font-size:medium;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;color:rgb(0,0,0);font-family:Helvetica;font-size:medium;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;color:rgb(0,0,0);font-family:Helvetica;font-size:12px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><span style="border-collapse:separate;color:rgb(0,0,0);font-family:Helvetica;font-size:12px;font-style:normal;font-variant:normal;font-weight:normal;letter-spacing:normal;line-height:normal;text-indent:0px;text-transform:none;white-space:normal;word-spacing:0px"><font size="2"><font face="Arial"><span style="font-size:10pt"><br></span></font></font></span></span></span></span></span></div></div></div></div></div></div></div></div></div></div></div></div></div><br><div class="gmail_quote"><div dir="ltr" class="gmail_attr">On Mon, Aug 30, 2021 at 7:22 AM Alexandra.EXCOFFIER-NOSOV--- via gnso-igo-wt <<a href="mailto:gnso-igo-wt@icann.org">gnso-igo-wt@icann.org</a>> wrote:<br></div><blockquote class="gmail_quote" style="margin:0px 0px 0px 0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
<div lang="EN-GB">
<div class="gmail-m_-9083183290360418243WordSection1">
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Thank you Mary and team,<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">I have the following main comments/questions on the documents:<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt">
<u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><span>-<span style="font:7pt "Times New Roman"">
</span></span></span><u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">In the places there is a mention of immunity “from process” – it should be “from legal process”<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt">
<u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><span>-<span style="font:7pt "Times New Roman"">
</span></span></span><u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Section 1.2 of the Draft Initial Report - Haven’t we moved beyond point (1) highlighted below with the registrant having
the choice to arbitrate or bring the claim to court? Should we add choice of law?
<i><u></u><u></u></i></span></p>
<p class="MsoNormal" style="margin-left:36pt"><i><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></i></p>
<p class="MsoNormal" style="margin-left:36pt"><i><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">“However, the EPDP team has not come to an agreed conclusion on the specific questions of (<span style="background:yellow">1)
whether the parties to a UDRP or URS case should have any review of the initial UDRP or URS determination decided solely through arbitration; and</span> (2) where a registrant prefers to file a case in court in lieu of arbitration, whether that registrant
should continue to be able to avail itself of the arbitration option after a court has declined jurisdiction over the registrant’s case based on an IGO’s jurisdictional immunity from legal process.”<u></u><u></u></span></i></p>
<p class="MsoNormal" style="margin-left:36pt"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">I believe the explanations which accompany recommendation 2C describe the issues better:
<i> “…(i) whether the option to arbitrate will remain available to a registrant following the outcome of a court proceeding initiated by the registrant in light of an IGO’s jurisdictional immunity from process, and (ii) what should be the applicable choice
of law…”</i><i><u></u><u></u></i></span></p>
<p class="MsoNormal" style="margin-left:36pt"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt">
<u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><span>-<span style="font:7pt "Times New Roman"">
</span></span></span><u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">The options for considerations (brackets) do not appear to be correctly placed :<u></u><u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:72pt">
<u></u><span lang="EN-US" style="font-size:12pt;font-family:"Courier New""><span>o<span style="font:7pt "Times New Roman"">
</span></span></span><u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Regarding the choice of arbitration vs court, the only brackets should be on what happens where the registrant loses
in court on immunity grounds: the original UDRP decision is implemented OR they have a right to request rehearing by arbitration. The rest of the text above that should remain un-bracketed and the two options should be spelled out; currently there is only
the second one, right of rehearing by arbitration<u></u><u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:72pt">
<u></u><span lang="EN-US" style="font-size:12pt;font-family:"Courier New""><span>o<span style="font:7pt "Times New Roman"">
</span></span></span><u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Similarly, concerning the options regarding applicable law, I had understood that the group agreed that mutual agreement
should always be sought and the registrant/registrar office choice applies only where there is no mutual agreement. The only bracketed text should be the IGO proposal for the arbitral tribunal to hear from the parties on the choice of law<u></u><u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal" style="margin-left:36pt">
<u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><span>-<span style="font:7pt "Times New Roman"">
</span></span></span><u></u><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Arbitral rules: please include also Permanent Court of Arbitration (PCA) rules
<a href="https://pca-cpa.org/en/home/" target="_blank"><span style="color:rgb(5,99,193)">https://pca-cpa.org/en/home/</span></a>. Also ICC? (strange that they are referred to in the footnote, but not in the body?) Also, I am personally not in favour of national rules such as
ICDR and I believe this was never discussed as an option in the group.<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Thank you,<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US" style="font-size:12pt;font-family:"Calibri Light",sans-serif">Alexandra<u></u><u></u></span></p>
<p class="MsoNormal"><span style="color:rgb(31,73,125)"><u></u> <u></u></span></p>
<p class="MsoNormal"><span style="color:rgb(31,73,125)"><u></u> <u></u></span></p>
<div>
<div style="border-right:none;border-bottom:none;border-left:none;border-top:1pt solid rgb(225,225,225);padding:3pt 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US">From:</span></b><span lang="EN-US"> gnso-igo-wt <<a href="mailto:gnso-igo-wt-bounces@icann.org" target="_blank">gnso-igo-wt-bounces@icann.org</a>>
<b>On Behalf Of </b>Mary Wong via gnso-igo-wt<br>
<b>Sent:</b> 26 August, 2021 8:06 PM<br>
<b>To:</b> <a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a><br>
<b>Subject:</b> [gnso-igo-wt] FOR REVIEW & DISCUSSION: UPDATED Draft Initial Report (EPDP on Specific Curative Rights Protections for IGOs)<u></u><u></u></span></p>
</div>
</div>
<p class="MsoNormal"><u></u> <u></u></p>
<p class="MsoNormal"><span lang="EN-US">Dear all,<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">At Chris’ request, and to facilitate your review of the Draft Initial Report from this EPDP team, staff has prepared an updated version that incorporates the substantive proposed revisions that Brian had sent to this
mailing list on Monday and which also reflects the GNSO Council’s initiation of the EPDP and the outcomes of this group’s Monday call.
<u>Please see the first attachment, showing these updates in “redline” format</u>. You should see Brian’s proposed edits and the subsequent staff updates in two different colors, with the staff updates under my name.
<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">To further assist with your review of the actual text of the preliminary recommendations as they currently stand, we have extracted the language (including the square-bracketed options under consideration) for Recommendation
#1 and Recommendation #2A, #2B and #2C – <u>please see the “clean” text in the second, separate attachment</u>.<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Please also note the following as you review this latest draft report:<u></u><u></u></span></p>
<ol style="margin-top:0cm" start="1" type="1">
<li class="MsoNormal"><span lang="EN-US">The substantive text of the preliminary recommendations (Section 2.1) is essentially identical to the language that we sent to you following the Monday call; you will see that we have
retained a few staff action items in the document, since, from the staff perspective, we think it will be easier to figure out how to best clarify the options and portray the “fork” in the arbitration path when we’re in a position to offer a clean version
of the language in question. In addition, the IGOs have also provided a proposed flow chart that you can see in the redlined report.<u></u><u></u></span></li><li class="MsoNormal"><span lang="EN-US">The draft report includes the new definition of IGO Complainant (as discussed on Monday’s call); as such, staff has removed all prior references to a lack of agreement amongst the EPDP
team on the scope of the definition.<u></u><u></u></span></li><li class="MsoNormal"><span lang="EN-US">You should only need to closely review Sections 1, 2 and 3. There is some redlined text in Section 4.1, which follows from alternative text in the previous sections about how to describe
immunity and court review, so we can easily update that paragraph after there’s agreement on what the text should actually say.<u></u><u></u></span></li></ol>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Thank you. We look forward to working with you to finalize the Draft Initial Report in time to meet our agreed deadline to publish it for Public Comment in early September.<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Cheers<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Steve, Berry & Mary<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
<div style="border-right:none;border-bottom:none;border-left:none;border-top:1pt solid rgb(181,196,223);padding:3pt 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:12pt;color:black">From:
</span></b><span lang="EN-US" style="font-size:12pt;color:black">Mary Wong <<a href="mailto:mary.wong@icann.org" target="_blank">mary.wong@icann.org</a>><br>
<b>Date: </b>Monday, August 23, 2021 at 7:53 PM<br>
<b>To: </b>Chris Disspain <<a href="mailto:chris@disspain.uk" target="_blank">chris@disspain.uk</a>>, "<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a>" <<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a>><br>
<b>Subject: </b>Following up on today's meeting (EPDP - Specific Curative Rights Protections IGOs for 23 Aug 2021 15:00 UTC Meeting)<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-US"><u></u> <u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-US">Hello everyone,<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">As Chris indicated in his note (below), please find attached the mark-up of the Draft Initial Report that Brian sent to this list, which staff has updated as follows. We have incorporated: (1) the updated definition of
“IGO Complainant”; and (2) the language that Brian, Alexandra and David had proposed to this list (with a small update to address Paul’s concern as noted via email) regarding the outcome of court proceedings where an IGO has not waived immunity and the result
is that the court declines to assume jurisdiction. <u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Both additions can be reviewed in Section 2 of the attached document (starting on Page 8). Staff has made notations in the document about other updates and action items that we will work on this week as well; you can
clearly see the staff notes as comments under my name.<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">We apologize in advance if the redline is difficult to read; however, maintaining this format shows more clearly all the suggested edits from Brian and the IGO representatives. As mentioned, we will be grateful if you
can send your concerns and issues for discussion to this list rather than mark up the redline; if helpful, you may wish to mention the relevant section and/or page number along with your comments.<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Thank you.<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Best regards,<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US">Steve, Berry & Mary<u></u><u></u></span></p>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<div style="border-right:none;border-bottom:none;border-left:none;border-top:1pt solid rgb(181,196,223);padding:3pt 0cm 0cm">
<p class="MsoNormal"><b><span lang="EN-US" style="font-size:12pt;color:black">From:
</span></b><span lang="EN-US" style="font-size:12pt;color:black">gnso-igo-wt <<a href="mailto:gnso-igo-wt-bounces@icann.org" target="_blank">gnso-igo-wt-bounces@icann.org</a>> on behalf of Chris Disspain via gnso-igo-wt <<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a>><br>
<b>Reply-To: </b>Chris Disspain <<a href="mailto:chris@disspain.uk" target="_blank">chris@disspain.uk</a>><br>
<b>Date: </b>Monday, August 23, 2021 at 12:40 PM<br>
<b>To: </b>"<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a>" <<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a>><br>
<b>Subject: </b>Re: [gnso-igo-wt] Agenda EPDP - Specific Curative Rights Protections IGOs for 23 Aug 2021 15:00 UTC Meeting</span><span lang="EN-US"><u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-US">Hello All, <u></u><u></u></span></p>
<div>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-US">Thank you for a very productive call today. Mary, Steve and Berry will send the 'next draft' of the document out soon. It will be the red line submitted by Brian et al with some additional red lines discussed today and
explanatory notes where text is still being worked on by staff (the 2c recommendation for example). <u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-US">Please take the time to consider the original text, the ‘Brian et al' suggested amendments and the additional staff redlines and provide comments, agreements or disagreements on the list. Also, please raise any other
points so we can address them as well.<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
</div>
<div>
<div>
<p class="MsoNormal"><span lang="EN-US" style="font-size:10pt;font-family:Verdana,sans-serif;color:black"><br>
</span><span lang="EN-US" style="font-size:10pt;font-family:Verdana,sans-serif;color:rgb(121,121,121)">Cheers,<br>
<br>
Chris<br>
<a href="mailto:chris@disspain.uk" target="_blank">chris@disspain.uk</a><br>
<br>
+44 7880 642456</span><span lang="EN-US" style="font-size:10pt;font-family:Verdana,sans-serif;color:black"><br>
<br>
</span><span lang="EN-US"><a>PastedGraphic-2.tiff</a>
<u></u><u></u></span></p>
</div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-US"><br>
<br>
<u></u><u></u></span></p>
<blockquote style="margin-top:5pt;margin-bottom:5pt">
<div>
<p class="MsoNormal"><span lang="EN-US">On 20 Aug 2021, at 22:33, Berry Cobb via gnso-igo-wt <<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a>> wrote:<u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
<div>
<div>
<p class="MsoNormal" style="margin-bottom:12pt"><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif">Dear EPDP - Specific Curative Rights Protections IGOs,<br>
<br>
Please see below the proposed agenda for the meeting scheduled on <b>23 Aug 2021 15:00 </b>UTC.</span><span lang="EN-US"><u></u><u></u></span></p>
<ul type="disc">
<li class="MsoNormal">
<span lang="EN-US">Roll Call & SOI Updates (2 minutes)<u></u><u></u></span></li><li class="MsoNormal">
<span lang="EN-US">Welcome & Chair updates (Chair) (10 minutes)</span><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif">
</span><span lang="EN-US"><u></u><u></u></span></li></ul>
<ul type="disc">
<ul type="circle">
<li class="MsoNormal">
<span lang="EN-US">GNSO Council </span><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif"><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Furldefense.com%2Fv3%2F__https%3A%2Fgnso.icann.org%2Fen%2Fcouncil%2Fresolutions%2F2020-current*20210819-2__%3BIw!!PtGJab4!tWQbOrM9QmEVWfhoLK6s-9_KNkDTvCTRfV9C2aq-YB-4rX7W0m7_ZmBGZR4YWgTZrYPkN-E%24&data=04%7C01%7CAlexandra.EXCOFFIER-NOSOV%40oecd.org%7C2c201da671b944269e4208d968bc2f86%7Cac41c7d41f61460db0f4fc925a2b471c%7C0%7C1%7C637655980034804466%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=6aDRXjlfdD7%2Bv5RbpgvUt7YNeXMo5NKX5tVQSovkX3M%3D&reserved=0" target="_blank"><span style="font-size:11pt;font-family:Calibri,sans-serif">procedural
decision [gnso.icann.org]</span></a></span><span lang="EN-US"> to maintain Work Track progress via Expedited Policy Development Process on Specific Curative Rights Protections for Intergovernmental Organizations<u></u><u></u></span></li></ul>
</ul>
<ul type="disc">
<li class="MsoNormal">
<span lang="EN-US">Continue Discussion of Working Proposals & Preliminary Conclusions (75 minutes)</span><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif">
</span><span lang="EN-US"><u></u><u></u></span></li></ul>
<ul type="disc">
<ul type="circle">
<li class="MsoNormal">
<span lang="EN-US">Group discussion & confirmation of proposed text on IGO privileges and immunities submitted by Brian, Alexandra & David (see
</span><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif"><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fmm.icann.org%2Fpipermail%2Fgnso-igo-wt%2F2021-August%2F000199.html&data=04%7C01%7CAlexandra.EXCOFFIER-NOSOV%40oecd.org%7C2c201da671b944269e4208d968bc2f86%7Cac41c7d41f61460db0f4fc925a2b471c%7C0%7C1%7C637655980034814425%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=zdrJUAGj2Cx%2BGrd5OU8L%2FdJyba6tveos1qq1iBrhtKM%3D&reserved=0" target="_blank"><span style="font-size:11pt;font-family:Calibri,sans-serif">https://mm.icann.org/pipermail/gnso-igo-wt/2021-August/000199.html</span></a></span><u><span lang="EN-US" style="color:blue">)</span></u><span lang="EN-US"><u></u><u></u></span></li><li class="MsoNormal">
<span lang="EN-US">Staff overview & group discussion of Draft Initial Report (see Executive Summary (pp. 2-6); Preliminary Recommendations (pp. 7-11); Proposed Impact Analysis (pp. 11-12):
</span><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif"><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fmm.icann.org%2Fpipermail%2Fgnso-igo-wt%2F2021-August%2F000194.html&data=04%7C01%7CAlexandra.EXCOFFIER-NOSOV%40oecd.org%7C2c201da671b944269e4208d968bc2f86%7Cac41c7d41f61460db0f4fc925a2b471c%7C0%7C1%7C637655980034814425%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=4Drswxw7vT0snVDBcaSe%2FmjI7VQX74Bkym6Tio9HWNs%3D&reserved=0" target="_blank"><span style="font-size:11pt;font-family:Calibri,sans-serif">https://mm.icann.org/pipermail/gnso-igo-wt/2021-August/000194.html</span></a></span><u><span lang="EN-US" style="color:blue">)</span></u><span lang="EN-US">
<u></u><u></u></span></li></ul>
</ul>
<ul type="disc">
<li class="MsoNormal">
<span lang="EN-US">Next steps & closing (3 minutes)</span><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif">
</span><span lang="EN-US"><u></u><u></u></span></li></ul>
<ul type="disc">
<ul type="circle">
<li class="MsoNormal">
<span lang="EN-US">Next meeting 30 August 2021 @ 15:00 UTC<u></u><u></u></span></li></ul>
</ul>
<p class="MsoNormal"><span lang="EN-US" style="font-size:10.5pt;font-family:Arial,sans-serif"><br>
<br>
Sincerely,<br>
<br>
GNSO Policy Staff</span><span lang="EN-US" style="border:1pt solid windowtext;padding:0cm"><img border="0" width="32" height="32" style="width: 0.3333in; height: 0.3333in;" id="gmail-m_-9083183290360418243_x0000_i1025" alt="Image removed by sender."></span><span lang="EN-US"><u></u><u></u></span></p>
</div>
<p class="MsoNormal"><span lang="EN-US">_______________________________________________<br>
gnso-igo-wt mailing list<br>
<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a><br>
<a href="https://mm.icann.org/mailman/listinfo/gnso-igo-wt" target="_blank">https://mm.icann.org/mailman/listinfo/gnso-igo-wt</a><br>
<br>
_______________________________________________<br>
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" target="_blank">https://www.icann.org/privacy/policy</a>)
and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" target="_blank">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery
or disabling delivery altogether (e.g., for a vacation), and so on.<u></u><u></u></span></p>
</div>
</blockquote>
</div>
<p class="MsoNormal"><span lang="EN-US"> <u></u><u></u></span></p>
</div>
</div>
</div>
_______________________________________________<br>
gnso-igo-wt mailing list<br>
<a href="mailto:gnso-igo-wt@icann.org" target="_blank">gnso-igo-wt@icann.org</a><br>
<a href="https://mm.icann.org/mailman/listinfo/gnso-igo-wt" rel="noreferrer" target="_blank">https://mm.icann.org/mailman/listinfo/gnso-igo-wt</a><br>
<br>
_______________________________________________<br>
By submitting your personal data, you consent to the processing of your personal data for purposes of subscribing to this mailing list accordance with the ICANN Privacy Policy (<a href="https://www.icann.org/privacy/policy" rel="noreferrer" target="_blank">https://www.icann.org/privacy/policy</a>) and the website Terms of Service (<a href="https://www.icann.org/privacy/tos" rel="noreferrer" target="_blank">https://www.icann.org/privacy/tos</a>). You can visit the Mailman link above to change your membership status or configuration, including unsubscribing, setting digest-style delivery or disabling delivery altogether (e.g., for a vacation), and so on.</blockquote></div>